AI has the potential to dramatically affect nearly all aspects of oncology—from enhancing diagnosis to personalizing treatment and discovering novel anticancer drugs. AI has been employed in the analysis of hematopathological, radiographic, laboratory, genomic, pharmacological, and chemical data to better inform diagnosis, prognosis, treatment planning, and foundational knowledge related to benign and malignant hematology. Keep up-to-date with all things AI in HemOnc on this channel.